Tapewire

Nasdaq · USD

TIPT

TIPTREE INC.

Export transactions ↓
Tapewire entity
5239
SEC CIK
0001393726
Parsed reports
515

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202610
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 26, 2020 Filed Mar 27, 2020 11:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,789 $5.46 $9,759.00
Disclosure

SEC source: 0001393726-20-000059 · wf-form4_158532401729847.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,216,113

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $5.35 to $5.58, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 26, 2020 Filed Mar 27, 2020 11:43 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $5.50 $1,100.00
Disclosure

SEC source: 0001393726-20-000057 · wf-form4_158532378341265.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,635

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 25, 2020 Filed Mar 27, 2020 11:47 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,789 $5.62 $10,061.34
Disclosure

SEC source: 0001393726-20-000059 · wf-form4_158532401729847.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,214,324

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $5.54 to $5.68, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 25, 2020 Filed Mar 27, 2020 11:43 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $5.17 $1,034.00
Disclosure

SEC source: 0001393726-20-000057 · wf-form4_158532378341265.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,835

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 24, 2020 Filed Mar 25, 2020 10:18 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,789 $5.05 $9,034.45
Disclosure

SEC source: 0001393726-20-000055 · wf-form4_158514588035909.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,212,535

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.19, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 24, 2020 Filed Mar 25, 2020 10:16 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $4.95 $990.00
Disclosure

SEC source: 0001393726-20-000053 · wf-form4_158514576291914.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,035

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 23, 2020 Filed Mar 25, 2020 10:18 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,789 $4.70 $8,415.46
Disclosure

SEC source: 0001393726-20-000055 · wf-form4_158514588035909.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,210,746

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.59 to $4.82, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 23, 2020 Filed Mar 25, 2020 10:16 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $4.68 $936.00
Disclosure

SEC source: 0001393726-20-000053 · wf-form4_158514576291914.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,235

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 20, 2020 Filed Mar 23, 2020 10:31 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,259 $4.87 $6,128.81
Disclosure

SEC source: 0001393726-20-000051 · wf-form4_158497388999965.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,208,957

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $4.80 to $4.90, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 20, 2020 Filed Mar 23, 2020 10:26 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $4.90 $980.00
Disclosure

SEC source: 0001393726-20-000049 · wf-form4_158497357712258.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,435

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 10:31 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,259 $5.07 $6,381.87
Disclosure

SEC source: 0001393726-20-000051 · wf-form4_158497388999965.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,207,698

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $4.90 to $5.19, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 19, 2020 Filed Mar 23, 2020 10:26 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $5.19 $1,038.00
Disclosure

SEC source: 0001393726-20-000049 · wf-form4_158497357712258.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,635

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 18, 2020 Filed Mar 19, 2020 09:28 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,259 $6.26 $7,881.34
Disclosure

SEC source: 0001393726-20-000045 · wf-form4_158462448520277.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,206,439

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.18 to $6.36, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 18, 2020 Filed Mar 19, 2020 09:30 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $6.36 $1,272.00
Disclosure

SEC source: 0001393726-20-000047 · wf-form4_158462462310877.xml · nonDerivative · entry 2

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,835

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 17, 2020 Filed Mar 19, 2020 09:28 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 1,259 $5.72 $7,201.48
Disclosure

SEC source: 0001393726-20-000045 · wf-form4_158462448520277.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,205,180

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 17, 2020 Filed Mar 19, 2020 09:30 UTC
Bell SandraChief Financial Officer
SaleCommon Stock 200 $5.72 $1,144.00
Disclosure

SEC source: 0001393726-20-000047 · wf-form4_158462462310877.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,035

F1 · kind: Pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 16, 2020 Filed Mar 17, 2020 13:48 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 3,900 $6.25 $24,375.00
Disclosure

SEC source: 0001393726-20-000043 · wf-form4_158445288364168.xml · nonDerivative · entry 2

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401K

Disclosed balance after: 29,440

Read SEC document
March 13, 2020 Filed Mar 17, 2020 13:48 UTC
Ilany JonathanDirector · Chief Executive Officer
PurchaseCommon Stock 690 $5.25 $3,622.50
Disclosure

SEC source: 0001393726-20-000043 · wf-form4_158445288364168.xml · nonDerivative · entry 1

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 401K

Disclosed balance after: 25,540

Read SEC document
March 02, 2020 Filed Mar 2, 2020 15:09 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,948 $6.71 $19,786.98
Disclosure

SEC source: 0001393726-20-000034 · wf-form4_158317976842213.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,203,921

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.66 to $6.79, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 15:09 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 24,078 $6.79 $163,561.85
Disclosure

SEC source: 0001393726-20-000034 · wf-form4_158317976842213.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,200,973

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.63 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 15:00 UTC
Bell SandraChief Financial Officer
Tax withholdingCommon Stock 6,910 $6.58 $45,467.80
Disclosure

SEC source: 0001393726-20-000030 · wf-form4_158317922705821.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,235

F1 · kind: Represents the total amount of shares withheld upon vesting of (1) the third and final of installment of restricted stock units issued to the Reporting Person on February 22, 2017, (2) the second installment of restricted stock units issued to the Reporting Person on February 26, 2018, and (3) the first installment of restricted stock units issued to the Reporting Person on February 26, 2019.

F2 · price: Represents the closing stock price as of the transaction date.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 15:06 UTC
Rifkind Neil CharlesGeneral Counsel and Secretary
Tax withholdingCommon Stock 7,219 $6.58 $47,501.02
Disclosure

SEC source: 0001393726-20-000032 · wf-form4_158317956490703.xml · nonDerivative · entry 1

Rifkind Neil Charles · CIK 0001580685 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,485

F1 · kind: Represents the total amount of shares withheld upon vesting of (1) the third and final installment of restricted stock units issued to the Reporting Person on February 22, 2017, (2) the second installment of restricted stock units issued to the Reporting Person on February 26, 2018, and (3) the first installment of restricted stock units issued to the Reporting Person on February 26, 2019.

F2 · price: Represents the closing stock price as of the transaction date.

Read SEC document
February 27, 2020 Filed Feb 27, 2020 17:11 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 20,476 $6.85 $140,178.70
Disclosure

SEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,176,895

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.83 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 26, 2020 Filed Feb 27, 2020 17:11 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 702 $6.85 $4,808.70
Disclosure

SEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,156,419

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 17:11 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,943 $6.85 $20,159.55
Disclosure

SEC source: 0001393726-20-000028 · wf-form4_158284149497934.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,155,717

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
February 20, 2020 Filed Feb 21, 2020 22:11 UTC
Ilany JonathanDirector · Chief Executive Officer
GrantEmployee Stock Option · Derivative 255,166 $0.00 Strike: $7.25 $0.00
Disclosure

SEC source: 0001393726-20-000024 · wf-form4_158232304392163.xml · derivative · entry 1

Ilany Jonathan · CIK 0001499150 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,166

Underlying: Common Stock · 255,166 shares

Expires 2030-02-20

F1 · security: The Reporting Person was granted non-qualified stock options to purchase 255,166 shares of common stock of the Registrant, subject to the terms of a Stock Option Agreement between the Registrant and the Reporting person (the "Stock Option Agreement").

F2 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 20, 2023, 2024 and 2025 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31, 2019 (as reported in the Registrant's filings with the Securities and Exchange Commission).

F3 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 20, 2030 and (2) the date of the termination of the Reporting Person's service with the Registrant for Cause (as defined in the Stock Option Agreement) or the Reporting Person's voluntary termination of service with the Registrant.

Read SEC document
February 20, 2020 Filed Feb 21, 2020 17:13 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
GrantEmployee Stock Option · Derivative 170,111 $0.00 Strike: $7.25 $0.00
Disclosure

SEC source: 0001393726-20-000026 · wf-form4_158232319418319.xml · derivative · entry 3

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 170,111

Underlying: Common Stock · 170,111 shares

Expires 2030-02-20

F3 · security: The Reporting Person was granted non-qualified stock options to purchase 170,111 shares of common stock of the Registrant, subject to the terms of a Stock Option Agreement between the Registrant and the Reporting person (the "Stock Option Agreement").

F4 · derivative.exercise_date: Exercise of the Stock Option is subject to both (1) a time-based vesting requirement with one-third vesting each of February 20, 2023, 2024 and 2025 and (2) a performance-based vesting requirement that, at any time during the option term, achievement of a 20-day volume weighted average stock price of Registrant's Common Stock, that exceeds the per share book value on an as exchanged basis as of December 31,2019 (as reported in the Registrant's filings with the Securities and Exchange Commission).

F5 · derivative.expiration_date: The Stock Option will expire on the earlier of (1) February 20, 2030 and (2) the date of the termination of Michael Barnes's service with the Registrant for Cause (as defined in the Stock Option Agreement) or Michael Barnes's voluntary termination of service with the Registrant.

Read SEC document
February 20, 2020 Filed Feb 21, 2020 17:13 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
GrantCommon Stock 85,055 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000026 · wf-form4_158232319418319.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,152,774

F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will cliff vest on February 15, 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement.

Read SEC document
February 20, 2020 Filed Feb 21, 2020 17:07 UTC
Bell SandraChief Financial Officer
GrantCommon Stock 16,004 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000022 · wf-form4_158232284827349.xml · nonDerivative · entry 1

Bell Sandra · CIK 0001447887 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,145

F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 15, 2021, 2022 and 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement.

Read SEC document
February 20, 2020 Filed Feb 21, 2020 17:05 UTC
Rifkind Neil CharlesGeneral Counsel and Secretary
GrantCommon Stock 16,004 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000020 · wf-form4_158232273302092.xml · nonDerivative · entry 1

Rifkind Neil Charles · CIK 0001580685 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,704

F1 · shares: The Reporting Person was granted restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, pursuant to the Issuer's Equity Plan. The restricted stock units will vest annually in three equal installments on each of February 15, 2021, 2022 and 2023 upon continuous employment from the grant date until such date, subject to certain terms contained in the Reporting Person's award agreement.

Read SEC document
January 31, 2020 Filed Feb 3, 2020 12:44 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,403 $6.85 $23,310.55
Disclosure

SEC source: 0001393726-20-000016 · wf-form4_158075187493772.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,067,719

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
January 07, 2020 Filed Jan 8, 2020 21:43 UTC GrantCommon Stock 2,308 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000004 · wf-form4_157851977894740.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,581

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2020 Filed Jan 8, 2020 16:44 UTC GrantCommon Stock 2,308 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000006 · wf-form4_157851987534188.xml · nonDerivative · entry 1

Mack John Edward · CIK 0001381172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,686

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2020 Filed Jan 8, 2020 16:47 UTC GrantCommon Stock 2,308 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000010 · wf-form4_157852005330529.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,241

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
January 07, 2020 Filed Jan 8, 2020 16:46 UTC GrantCommon Stock 2,308 $0.00 $0.00
Disclosure

SEC source: 0001393726-20-000008 · wf-form4_157851996655671.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,238

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 03, 2019 Filed Oct 4, 2019 14:08 UTC GrantCommon Stock 2,563 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000160 · wf-form4_157019811080993.xml · nonDerivative · entry 1

Goldwasser Lesley · CIK 0001465575 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,273

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 03, 2019 Filed Oct 4, 2019 10:07 UTC GrantCommon Stock 2,563 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000158 · wf-form4_157019799983607.xml · nonDerivative · entry 1

Mack John Edward · CIK 0001381172 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,378

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 03, 2019 Filed Oct 4, 2019 10:10 UTC GrantCommon Stock 2,563 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000162 · wf-form4_157019821194650.xml · nonDerivative · entry 1

Smith Bradley E. · CIK 0001579089 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,930

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

Read SEC document
October 03, 2019 Filed Oct 4, 2019 10:12 UTC GrantCommon Stock 2,563 $0.00 $0.00
Disclosure

SEC source: 0001393726-19-000164 · wf-form4_157019833500631.xml · nonDerivative · entry 1

Friedman Paul M · CIK 0001648181 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,933

F1 · shares: Represents the stock component of the director's annual retainer fee, which is paid quarterly in arrears.

F2 · balance_after: The total direct beneficial ownership reflects a decrease of 4,000 shares due to the transfer of 4,000 shares into the reporting person's Living Trust on 07/26/2019.

Read SEC document
September 04, 2019 Filed Sep 5, 2019 10:04 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 3,128 $6.83 $21,364.24
Disclosure

SEC source: 0001393726-19-000156 · wf-form4_156769222868084.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,064,316

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.805 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
September 03, 2019 Filed Sep 5, 2019 10:04 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 4,798 $6.87 $32,957.46
Disclosure

SEC source: 0001393726-19-000156 · wf-form4_156769222868084.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,061,188

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.84 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 30, 2019 Filed Sep 3, 2019 10:34 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 400 $6.88 $2,752.00
Disclosure

SEC source: 0001393726-19-000154 · wf-form4_156752126855251.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,056,390

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 29, 2019 Filed Sep 3, 2019 10:34 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 5,600 $6.86 $38,421.60
Disclosure

SEC source: 0001393726-19-000154 · wf-form4_156752126855251.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,055,990

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.83 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 28, 2019 Filed Aug 29, 2019 11:18 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,602 $6.86 $17,857.53
Disclosure

SEC source: 0001393726-19-000152 · wf-form4_156709186817555.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,050,390

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.85 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 27, 2019 Filed Aug 29, 2019 11:18 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 6,764 $6.83 $46,204.88
Disclosure

SEC source: 0001393726-19-000152 · wf-form4_156709186817555.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,047,788

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.81 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 26, 2019 Filed Aug 27, 2019 12:30 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,020 $6.74 $13,616.82
Disclosure

SEC source: 0001393726-19-000150 · wf-form4_156692342649255.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,041,024

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.63 to $6.85, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 23, 2019 Filed Aug 27, 2019 12:30 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 11,786 $6.61 $77,881.89
Disclosure

SEC source: 0001393726-19-000150 · wf-form4_156692342649255.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,039,004

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.55 to $6.65, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 22, 2019 Filed Aug 23, 2019 11:13 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 17,487 $6.73 $117,670.02
Disclosure

SEC source: 0001393726-19-000148 · wf-form4_156657320885428.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,027,218

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.60 to $6.87, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 21, 2019 Filed Aug 23, 2019 11:13 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 7,413 $6.82 $50,527.01
Disclosure

SEC source: 0001393726-19-000148 · wf-form4_156657320885428.xml · nonDerivative · entry 1

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,009,731

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F2 · price: This purchase was executed in multiple purchases at prices ranging from $6.77 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 20, 2019 Filed Aug 21, 2019 10:07 UTC
Barnes Michael GeneDirector · Executive Chairman · 10% owner
PurchaseCommon Stock 2,446 $6.75 $16,503.16
Disclosure

SEC source: 0001393726-19-000146 · wf-form4_156639641330396.xml · nonDerivative · entry 2

Barnes Michael Gene · CIK 0001498811 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,002,318

F1 · kind: Purchases pursuant to a Rule 10b5-1 trading plan.

F3 · price: This purchase was executed in multiple purchases at prices ranging from $6.69 to $6.88, inclusive. The price reported above reflects the weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.